Skip to main content

Solésence Inc. Value Stock - Dividend - Research Selection

Nanophase technologies

ISIN: US6300791018 , WKN: 910885

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Nanophase Technologies Corporation develops and manufactures advanced materials and applications with an integrated nanomaterial and related technologies. It produces engineered nano and larger, and sub-micron materials for use in various markets, which comprise personal care, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy, and various surface finishing technologies. The company was founded in 1989 and is headquartered in Romeoville, Illinois.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

2026-05-14
The report, led by the United Kingdom’s APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, build public awareness and combat misinformation. From left the photo includes: Carolyn Harris, MP, Chair of the APPG for Beauty, Hair & Wellbeing, Victoria Brownlie MBE, Chief Policy & Sustainability Officer, British Beauty Council, Emma Harper, Executive Director, Strategy, Marketing, and Communicat

Solesence Inc (SLSN) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

2026-05-12
Solesence Inc (SLSN) reports a revenue dip but remains optimistic about future growth through new technologies and improved operational strategies.

Solesence, Inc. Common Stock Q1 2026 Earnings Call Summary

2026-05-12
Moby summary of Solesence, Inc. Common Stock's Q1 2026 earnings call

Gross Margin Expansion Highlights Solésence’s Operational Restructuring Efforts (SLSN)

2026-05-12
Solésence reported improved gross margin in the first quarter despite lower revenue and a return to a net loss, as the company continued executing its Transform & Transcend strategic initiative. Key Investor TakeawaysSolésence (NASDAQ:SLSN) posted first-quarter revenue of $13.

Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

2026-05-12
Solesence, Inc. (SLSN) Q1 2026 Earnings Call May 12, 2026 8:30 AM EDTCompany ParticipantsKevin Cureton - President, CEO & DirectorLaura Riffner - Chief...

Transcript : Solesence, Inc., Q1 2026 Earnings Call, May 12, 2026

2026-05-12
Presentation Operator MessageOperator Good day, and thank you for standing by. Welcome to the Solesence First Quarter 2026 Conference Call. Today's call is being recorded. On today's call, we have...

Solésence Reports First Quarter 2026 Financial Results

2026-05-12
Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026. “In March, we introduced Transform and Transcend to our investor community, the strategic initiative

Solesence, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

2026-05-12
Solesence, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 12.96 million compared to USD 14.63 million a year...

Solesence Reports Q1 2026 Results: Full Earnings Call Transcript

2026-05-12

Solesence Q1 EPS $(0.01), Sales $12.957M Down From $14.625M YoY

2026-05-12
Solesence (NASDAQ:SLSN) reported quarterly losses of $(0.01) per share. The company reported $12.957 million in sales this quarter. This is a 11.41 percent decrease over sales of $14.625 million the same period last